Similar articles

• Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes.

  Weir GC, Leahy JL, Bonner-Weir S. Weir GC, et al. Diabetes Metab Rev. 1986;2(1-2):125-61. doi: 10.1002/dmr.5610020108. Diabetes Metab Rev. 1986. PMID: 2424696 Review. No abstract available.
• Effect of islet-activating protein (IAP), purified from the culture medium of Bordetella pertussis, on the secretion of immunoreactive insulin and glucagon in normal, alloxan-treated, and depancreatized dogs.

  Yoshida T, Nakamura Y, Nakano K, Kondo M. Yoshida T, et al. Diabetes. 1981 May;30(5):430-4. doi: 10.2337/diab.30.5.430. Diabetes. 1981. PMID: 6262169 No abstract available.
• [Animal models of non-insulin-dependent diabetes induced in the rat by experimental reduction of B cell mass].

  Portha B, Giroix MH, Kergoat M, Bailbe D, Blondel O, Serradas P. Portha B, et al. Journ Annu Diabetol Hotel Dieu. 1988:33-46. Journ Annu Diabetol Hotel Dieu. 1988. PMID: 2971833 Review. French. No abstract available.
• Flow cytometric quantification of glucose-stimulated beta-cell metabolic flux can reveal impaired islet functional potency.

  Hanson MS, Steffen A, Danobeitia JS, Ludwig B, Fernandez LA. Hanson MS, et al. Cell Transplant. 2008;17(12):1337-47. doi: 10.3727/096368908787648038. Cell Transplant. 2008. PMID: 19364071
• Effects of alloxan on the islets of Langerhans: stimulation and inhibition of cyclic AMP production.

  Borg LA, Bone AJ. Borg LA, et al. J Cyclic Nucleotide Protein Phosphor Res. 1985;10(4):361-9. J Cyclic Nucleotide Protein Phosphor Res. 1985. PMID: 2993386